Truseltiq Alternatives Compared
| Truseltiq (infigratinib) | Imfinzi (durvalumab) | Tibsovo (ivosidenib) |
|
|---|
| Truseltiq (infigratinib) | Imfinzi (durvalumab) | Tibsovo (ivosidenib) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Biliary Tract Tumor. Truseltiq may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Small Cell Lung Cancer, Non Small Cell Lung Cancer, Biliary Tract Tumor, Hepatocellular Carcinoma, Endometrial Cancer, Bladder Cancer. Imfinzi may also be used for purposes not listed... View more |
Prescription only
Prescribed for Biliary Tract Tumor, Myelodysplastic Syndrome, Acute Myeloid Leukemia. Tibsovo may also be used for purposes not listed in this medication guide. |
Related suggestions Biliary Tract Tumor
|
|||||||||||||||
| More about Truseltiq (infigratinib) | More about Imfinzi (durvalumab) | More about Tibsovo (ivosidenib) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Imfinzi has an average rating of 8.7 out of 10 from a total of 6 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 0% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Truseltiq side effects |
View all Imfinzi side effects |
View all Tibsovo side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Imfinzi prices |
View all Tibsovo prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
33.5 hours |
408 hours |
129 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 206 drugs are known to interact with Truseltiq:
|
A total of 624 drugs are known to interact with Imfinzi:
|
A total of 580 drugs are known to interact with Tibsovo:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
May 28, 2021 |
May 01, 2017 |
July 20, 2018 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Ziihera
Ziihera (zanidatamab) is a bispecific HER2-directed antibody used to treat HER2-positive biliary ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.